COVID-19 Risk in Breast Cancer Patients Receiving CDK4/6 Inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Breast Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
COVID-19 Risk in Breast Cancer Patients Receiving CDK4/6 Inhibitors: Literature Data and a Monocentric Experience
Breast J 2021 Mar 06;[EPub Ahead of Print], M Barba, E Krasniqi, L Pizzuti, M Mazzotta, D Marinelli, G Giuliano, FS Di Liso, F Cappuzzo, L Landi, S Tomao, G Ciliberto, P ViciFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.